---
class: Inotrope
chemistry: Endogenous catecholamine
dose:
    arrest: 1mg IV
    shock: 0.05-2µg/kg/min IV
    anaphylaxis:
        - "No IV access: 500μg IM Q5 min"
        - "Grade II: 20μg IV"
        - "Grade III: 100-200μg IV"
    airway oedema: 5mg neb
pharmaceutics:
    presentation: Clear, colourless solution typically at 0.1-1mg/ml in a brown glass ampoule
pharmacokinetics:
    absorption:
        - No PO bioavailability due to destruction by COMT and MAO in the gut brush border
        - Variable ETT and SC absorption
    distribution:
        pKa: 9.69
        vd: 0.1-0.2L/kg
        protein binding: 12%
    metabolism:
        half-life: 2 minutes
        pathway: Metabolised rapidly and completely by mitochondrial MAO and COMT within liver, kidney, and blood
        metabolites:
            - VMA
            - Metadrenaline
    elimination:
        renal: Metabolites
mechanism: Active at all adrenoreceptors. β > α at lower doses. α1 effects dominate at high doses.
pharmacodynamics:
    resp:
        - ↑ MV
        - Bronchodilation
    cvs: 
        - ↑ Inotropy
        - ↑ HR
        - ↑ SVR and PVR
        - ↑ BP
        - ↑ CO
        - ↑ Myocardial O2 consumption
        - Coronary vasodilation
        - Arrhythmogenic
    cns:
        - ↑ Pain threshold
        - ↑ MAC
    endo:
    msk:
        - Necrosis with extravasation
    met:
        - ↑ BMR
        - ↑ Lipolysis
        - ↑ Gluconeogenesis and BSL
        - ↑ Lactate
        - Initially ↑ insulin secretion (β), then ↓ (α)
    ren:
        - ↓ RBF
        - ↑ In sphincter tone
    gu:
    git:
    haeme:
